PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFfp
Ffp
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
85 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HemorrhageD006470MP_0001914R582416820
Blood coagulation disordersD001778EFO_0009314D68.9122239
Hemostatic disordersD020141122239
Liver cirrhosisD008103EFO_0001422K74.02136
Intracranial hemorrhagesD020300EFO_0000551I621124
Cerebral hemorrhageD0025431214
Heart diseasesD006331EFO_0003777I51.91124
Cardiac surgical proceduresD00634833
Surgical blood lossD0160631113
Abdominal aortic aneurysmD017544EFO_0004214123
Show 19 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Covid-19D00008638221238
LeukemiaD007938C952114
Wounds and injuriesD014947T14.823114
B-cell chronic lymphocytic leukemiaD015451C91.1213
Lymphoid leukemiaD007945C91213
Traumatic brain injuriesD000070642S061223
Brain injuriesD001930S06.91223
Thrombotic thrombocytopenic purpuraD011697M31.19112
Thrombocytopenic purpuraD011696112
PurpuraD011693HP_0000979D69.2112
Show 5 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cytokine release syndromeD000080424D89.83123
Congenital heart defectsD006330HP_0001627Q24.9123
SyndromeD013577112
Kidney transplantationD016030122
Transfusion reactionD065227D69.51112
Septic shockD012772A48.322
ShockD012769R57.122
Coagulation protein disordersD020147112
Hereditary angioedemasD054179EFO_000413111
Graft rejectionD00608411
Show 6 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients11
Hematologic neoplasmsD01933711
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
FibrosisD00535533
Bone fracturesD050723EFO_0003931T14.833
Hip fracturesD006620EFO_0003964S72.0022
BurnsD002056T30.022
Critical illnessD01663811
Myeloid leukemia acuteD015470C92.011
Myeloid leukemiaD007951C9211
Premature birthD047928EFO_0003917O6011
Premature rupture fetal membranesD005322HP_0001788O4211
RuptureD01242111
Show 29 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use